000 01663 a2200529 4500
005 20250515054413.0
264 0 _c20070405
008 200704s 0 0 eng d
022 _a0268-3369
024 7 _a10.1038/sj.bmt.1705580
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQazilbash, M H
245 0 0 _aAutologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
_h[electronic resource]
260 _bBone marrow transplantation
_cMar 2007
300 _a279-83 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelphalan
_xadministration & dosage
650 0 4 _aMultiple Myeloma
_xmortality
650 0 4 _aMyeloablative Agonists
_xadministration & dosage
650 0 4 _aPeripheral Blood Stem Cell Transplantation
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
650 0 4 _aTransplantation, Autologous
700 1 _aSaliba, R M
700 1 _aHosing, C
700 1 _aMendoza, F
700 1 _aQureshi, S R
700 1 _aWeber, D M
700 1 _aWang, M
700 1 _aFlosser, T
700 1 _aCouriel, D R
700 1 _aDe Lima, M
700 1 _aKebriaei, P
700 1 _aPopat, U
700 1 _aAlousi, A M
700 1 _aChamplin, R E
700 1 _aGiralt, S A
773 0 _tBone marrow transplantation
_gvol. 39
_gno. 5
_gp. 279-83
856 4 0 _uhttps://doi.org/10.1038/sj.bmt.1705580
_zAvailable from publisher's website
999 _c16823749
_d16823749